The threat posed by antimicrobial resistance is urgent and spares no country - including Brazil. According to The Lancet, 63 deaths per 100,000 are associated with AMR in Brazil and Paraguay, a rate that exceeds the average for Latin America and the Caribbean. AMR-associated deaths in Brazil are second only to cardiovascular diseases and cancers.

What if the medicines we rely on to overcome infections are no longer able to protect us from known diseases that would become potentially fatal? Unfortunately, that's what we're about to see happen.